5 Days
Source:
AL24 News
Oxford begins trial for Bondi Phogyo Ebola vaccine
Oxford University has launched its first human clinical trial for a vaccine against the Bundibugyo strain of the Ebola virus, aiming to accelerate efforts to combat the outbreak in the Democratic Republic of Congo and Uganda. The vaccine uses a technology similar to that of the COVID-19 vaccine developed by the university and has been manufactured in collaboration with the Indian Serum Institute, which prepared 620,000 ready-to-use doses. The trial was conducted over just eight weeks thanks to rapid international cooperation. The team will continue to recruit volunteers and evaluate the vaccine's safety and effectiveness amid the ongoing outbreak of the strain, which has resulted in over a thousand deaths since May. If the vaccine proves to be safe and effective, it is expected that it will be licensed for widespread use in the upcoming phase.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)